Who is sponsoring NCT04169152?

NCT04169152 is sponsored by Faming Zhang.

What drugs are being tested in NCT04169152?

Interventions in NCT04169152: Cap-assisted endoscopic sclerotherapy.

What condition does NCT04169152 study?

NCT04169152 studies Internal Hemorrhoid, Rectal Prolapse.

Is NCT04169152 still recruiting?

NCT04169152 is currently recruiting now. Last updated 2 April 2024.

Last reviewed 2024-04-02 · How we verify

NCT04169152

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

CAES for Internal Hemorrhoids and Rectal Prolapse

Recruiting now Last updated 2 April 2024

What this trial tests

trial testing Cap-assisted endoscopic sclerotherapy in Internal Hemorrhoid in 10,000 participants. Currently enrolling.

Timeline

30 December 2019

Primary endpoint
30 December 2027

30 June 2028

Quick facts

Lead sponsor	Faming Zhang
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	10,000
Start date	30 December 2019
Primary completion	30 December 2027
Estimated completion	30 June 2028
Sites	1 location across China

Drugs / interventions tested

Cap-assisted endoscopic sclerotherapy

Conditions studied

Internal Hemorrhoid — all drugs for Internal Hemorrhoid →
Rectal Prolapse — all drugs for Rectal Prolapse →

Sponsor

Faming Zhang

Who can join

Eligibility, any sex, with Internal Hemorrhoid or Rectal Prolapse. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cap-assisted endoscopic sclerotherapy (CAES) is a new interventional therapy for internal hemorrhoids and rectal prolapse under colonoscopy. However, the long-term efficacy and safety of CAES in the treatment of internal hemorrhoids and rectal prolapse are still not clear due to the lack of large sample studies. Therefore, a nationwide multi-center, large sample, prospective and cohort study was designed to evaluate the efficacy and safety of CAES in the treatment of internal hemorrhoids and rectal prolapse, to provide reliable evidence for popularization of this minimally invasive technology.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Latest Research Trends on the Management of Hemorrhoids.
Kang SI. · · 2025 · cited 3× · PMID 40302863 · DOI 10.23922/jarc.2024-090

Verify or expand the search:

Other recruiting trials for Internal Hemorrhoid

Currently open trials in the same condition.

NCT03917056 — Cap-assisted Endoscopic Sclerotherapy for Internal Hemorrhoids and Rectal Prolapse · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04169152 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Faming Zhang
Last refreshed: 2 April 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04169152.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing